Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PROKIDNEY CORP. Director's Dealing 2022

Oct 24, 2022

32485_dirs_2022-10-24_e55f4a7c-b50c-4925-a592-b03cb481d11d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PROKIDNEY CORP. (PROK)
CIK: 0001850270
Period of Report: 2022-10-20

Reporting Person: Girolamo Todd C (Chief Legal Officer)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2022-10-20 Employee stock option (right to buy) $10.33 A 696793 Acquired 2032-10-20 Class A Ordinary Shares (696793) Direct

Footnotes

F1: The option vests in substantially equal monthly installments over the four year period beginning on October 19, 2022.